TABLE 1.
Demographic and clinical characteristics of 131 patients.
| Group | Case (n) | Age (years) | Gender (male/female) | DM duration (years) | FBS (mmol/L) | HbA1c (%) | TG (mmol/L) | TC (mmol/L) | LDL-C (mmol/L) | Percentage of BF(+) |
| A | 34 | 55.5 ± 9.4 | 15/19 | 5.3 ± 3.9 | 9.3 ± 4.6 | 8.2 ± 2.7 | 4.5 ± 1.2 | 5.3 ± 2.1 | 4.0 ± 0.6 | 58.8% |
| B | 31 | 50.3 ± 8.3 | 20/11 | 6.7 ± 4.2 | 9.8 ± 3.6 | 8.8 ± 2.2 | 3.9 ± 1.3 | 5.5 ± 1.5 | 3.8 ± 0.6 | 48.4% |
| C | 35 | 46.7 ± 12.3 | 18/17 | 0 | 4.3 ± 1.3a | 3.1 ± 1.1a | 1.5 ± 0.9a | 5.0 ± 1.4 | 2.5 ± 0.7a | 28.6%a |
| D | 31 | 52.5 ± 14.6 | 13/18 | 0 | 4.5 ± 0.8a | 2.9 ± 1.2a | 2.1 ± 1.4a | 3.8 ± 1.2b | 2.8 ± 0.5a | 32.3%a |
DM, diabetes mellitus; FBS, fasting blood glucose; TC, total cholesterol; TG, total glyceride; LDL-C, LDL cholesterol; BF, biofilm; acompared with Group A and B, P < 0.05; bcompared with groups A–C, P < 0.05.